• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why DigitalOcean Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

    11/3/23 8:41:43 AM ET
    $AAPL
    $ARBB
    $BDRX
    $BILL
    Computer Manufacturing
    Technology
    EDP Services
    Technology
    Get the next $AAPL alert in real time by email

    Gainers

    Altamira Therapeutics Ltd (NASDAQ:CYTO) shares surged 54.1% to $0.25 in pre-market trading after gaining 5% on Thursday.

    Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) shares rose 22.5% to $0.37 in pre-market trading after gaining more than 7% on Thursday.

    DigitalOcean Holdings, Inc. (NASDAQ:DOCN) rose 19.6% to $25.40 in pre-market trading after the company reported better-than-expected third-quarter financial results and issued FY23 guidance.

    Block, Inc. (NYSE:SQ) shares climbed 18.6% to $52.18 in pre-market trading after the company reported better-than-expected third-quarter financial results and issued fourth-quarter guidance.

    Novo Integrated Sciences, Inc. (NASDAQ:NVOS) shares gained 18.1% to $0.3054 in pre-market trading after gaining more than 10% on Thursday.

    EZGO Technologies Ltd (NASDAQ:EZGO) shares jumped 16.1% to $0.12 in pre-market trading after climbing 13% on Thursday.

    DermTech Inc (NASDAQ:DMTK) rose 14.4% to $1.60 in pre-market trading after the company reported better-than-expected third-quarter financial results.

    Hippo Holdings Inc (NYSE:HIPO) shares rose 12.9% to $9.08 in pre-market trading after the company reported better-than-expected third-quarter financial results.

    Inflarx NV (NASDAQ:IFRX) gained 12.1% to $1.57 in pre-market trading after falling around 14% on Thursday.

    Rail Vision Ltd (NASDAQ:RVSN) shares rose 9.4% to $0.37 in pre-market trading after jumping 15% on Thursday.

    Losers

    BILL Holdings Inc (NYSE:BILL) dipped 33.6% to $59.44 in pre-market trading after the company reported first-quarter results and lowered its FY24 revenue outlook.

    Fortinet Inc (NASDAQ:FTNT) shares fell 24% to $43.80 in pre-market trading after the company reported mixed third-quarter financial results and issued FY23 revenue guidance below estimates.

    Inseego Corp (NASDAQ:INSG) shares fell 23.1% to $0.40 in pre-market trading after the company reported worse-than-expected third-quarter financial results.

    Fox Factory Holding Corp (NASDAQ:FOXF) shares fell 17.1% to $68.95 in pre-market trading after the company reported downbeat third-quarter results and issued weak fourth-quarter forecast.

    Mountain Crest Acquisition Corp IV (NASDAQ:MCAF) shares fell 15% to $9.40 in pre-market trading after gaining over 5% on Thursday.

    Biodexa Pharmaceuticals PLC-ADR (NASDAQ:BDRX) shares fell 14.1% to $3.30 in pre-market trading.

    Invo Bioscience Inc (NASDAQ:INVO) fell 13.1% to $1.13 in pre-market trading after gaining 8% on Thursday.

    Secoo Holding Ltd - ADR (NASDAQ:SECO) fell 11.2% to $0.65 in pre-market after falling 4% on Thursday.

    ARB IOT Group Ltd (NASDAQ:ARBB) fell 10% to $0.78 in pre-market trading after declining 5% on Thursday.

    Apple Inc (NASDAQ:AAPL) shares fell 3.3% to $171.80 in pre-market trading. Apple reported stronger-than-expected earnings and sales results for its fourth quarter on Thursday. However, the company’s iPhone revenue came in slightly shy of expectations.

    Now Read This: $1.5M Bet On This Financial Services Stock? Check Out These 4 Stocks Insiders Are Buying

    Get the next $AAPL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAPL
    $ARBB
    $BDRX
    $BILL

    CompanyDatePrice TargetRatingAnalyst
    Apple Inc.
    $AAPL
    3/5/2026$267.00 → $268.00Neutral
    Rosenblatt
    Apple Inc.
    $AAPL
    3/3/2026$239.00 → $248.00Underweight
    Barclays
    Fortinet Inc.
    $FTNT
    3/3/2026$64.00Underweight
    Wells Fargo
    Apple Inc.
    $AAPL
    2/25/2026$241.00 → $270.00Neutral
    MoffettNathanson
    Apple Inc.
    $AAPL
    2/10/2026$325.00 → $340.00Outperform
    Bernstein
    Fortinet Inc.
    $FTNT
    2/9/2026$90.00 → $95.00Market Perform
    BMO Capital Markets
    BILL Holdings Inc.
    $BILL
    2/6/2026$50.00 → $46.00Market Perform
    BMO Capital Markets
    DigitalOcean Holdings Inc.
    $DOCN
    2/5/2026$68.00Neutral → Overweight
    Cantor Fitzgerald
    More analyst ratings

    $AAPL
    $ARBB
    $BDRX
    $BILL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Hippo Holdings Inc.

    4 - Hippo Holdings Inc. (0001828105) (Issuer)

    3/11/26 5:06:07 PM ET
    $HIPO
    Property-Casualty Insurers
    Finance

    SEC Form 4 filed by Fox Factory Holding Corp.

    4 - FOX FACTORY HOLDING CORP (0001424929) (Issuer)

    3/11/26 4:06:58 PM ET
    $FOXF
    Motor Vehicles
    Consumer Discretionary

    Chief Legal Officer Merchant Toby D was granted 23,546 shares, increasing direct ownership by 69% to 57,759 units (SEC Form 4)

    4 - FOX FACTORY HOLDING CORP (0001424929) (Issuer)

    3/11/26 4:06:52 PM ET
    $FOXF
    Motor Vehicles
    Consumer Discretionary

    $AAPL
    $ARBB
    $BDRX
    $BILL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Zeltser Guy bought $4,808 worth of shares (665 units at $7.23) and covered exercise/tax liability with 4,483 shares, decreasing direct ownership by 6% to 65,042 units (SEC Form 4)

    4 - Hippo Holdings Inc. (0001828105) (Issuer)

    2/18/26 7:02:59 PM ET
    $HIPO
    Property-Casualty Insurers
    Finance

    Chief Executive Officer Dennison Michael C. bought $312,321 worth of shares (22,000 units at $14.20), increasing direct ownership by 10% to 246,786 units (SEC Form 4)

    4 - FOX FACTORY HOLDING CORP (0001424929) (Issuer)

    11/17/25 4:01:24 PM ET
    $FOXF
    Motor Vehicles
    Consumer Discretionary

    Director North Sound Trading, Lp bought $479,504 worth of shares (55,001 units at $8.72) (SEC Form 4)

    4 - INSEEGO CORP. (0001022652) (Issuer)

    8/14/25 7:08:42 PM ET
    $INSG
    Telecommunications Equipment
    Telecommunications

    $AAPL
    $ARBB
    $BDRX
    $BILL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 17, 2024 - FDA Roundup: September 17, 2024

    For Immediate Release: September 17, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice,” which, when finalized, will support the conduct of randomized controlled trials with streamlined protocols a

    9/17/24 2:34:22 PM ET
    $AAPL
    Computer Manufacturing
    Technology

    September 12, 2024 - FDA Authorizes First Over-the-Counter Hearing Aid Software

    For Immediate Release: September 12, 2024 Today, the U.S. Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended to be used with compatible versions of the Apple AirPods Pro headphones. Once installed and customized to the user’s hearing needs, the Hearing Aid Feature enables compatible versions of the AirPods Pro to serve as an OTC hea

    9/12/24 10:58:17 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    $AAPL
    $ARBB
    $BDRX
    $BILL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $AAPL
    $ARBB
    $BDRX
    $BILL
    SEC Filings

    View All

    $AAPL
    $ARBB
    $BDRX
    $BILL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    InflaRx Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

    JENA, Germany, March 13, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (NASDAQ:IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that it has received a written notice (the "Notice"), dated March 11, 2026, from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that, for the last thirty (30) consecutive business days, the bid price for the Company's ordinary shares had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq under Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Rule"). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the

    3/13/26 5:00:00 PM ET
    $IFRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    InflaRx to Report Full Year 2025 Results on March 19, 2026

    JENA, Germany, March 12, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (NASDAQ:IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company will publish its financial and operating results for the fourth quarter and full year 2025 on March 19, 2026, before the market opens. No conference call is planned. About InflaRxInflaRx (NASDAQ:IFRX) is a biopharmaceutical company pioneering anti-inflammatory therapeutics by applying its proprietary anti-C5a and anti-C5aR technologies to discover, develop and commercialize highly potent and specific inhibitors of the complement activation factor C5a and its receptor, C5aR. C

    3/12/26 7:30:00 AM ET
    $IFRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Fortinet Introduces FortiOS 8.0 to Expand Secure Networking with Secure AI Controls, Fabric-based AI Agents, Flexible SASE, and Simplified SD-WAN

    SUNNYVALE, Calif. and LAS VEGAS, March 10, 2026 (GLOBE NEWSWIRE) -- Fortinet® (NASDAQ:FTNT), the global cybersecurity leader driving the convergence of networking and security, today announced FortiOS 8.0, the latest release of the operating system that powers the Fortinet Security Fabric. Introduced as part of Fortinet's Secure Networking innovation at Fortinet Accelerate 2026, FortiOS 8.0 delivers powerful new AI-driven security, next-generation SASE, and quantum-safe capabilities to help organizations simplify their security architectures while delivering consistent protection and performance across the entire digital infrastructure. "FortiOS 8.0 reflects more than 25 years of contin

    3/10/26 9:00:00 AM ET
    $FTNT
    Computer peripheral equipment
    Technology

    SEC Form 144 filed by DigitalOcean Holdings Inc.

    144 - DigitalOcean Holdings, Inc. (0001582961) (Subject)

    3/10/26 12:27:05 PM ET
    $DOCN
    Computer Software: Programming Data Processing
    Technology

    SEC Form 144 filed by Hippo Holdings Inc.

    144 - Hippo Holdings Inc. (0001828105) (Subject)

    3/9/26 4:26:16 PM ET
    $HIPO
    Property-Casualty Insurers
    Finance

    SEC Form 6-K filed by Rail Vision Ltd.

    6-K - Rail Vision Ltd. (0001743905) (Filer)

    3/6/26 4:05:27 PM ET
    $RVSN
    Railroads
    Industrials

    Rosenblatt reiterated coverage on Apple with a new price target

    Rosenblatt reiterated coverage of Apple with a rating of Neutral and set a new price target of $268.00 from $267.00 previously

    3/5/26 8:07:39 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    Barclays reiterated coverage on Apple with a new price target

    Barclays reiterated coverage of Apple with a rating of Underweight and set a new price target of $248.00 from $239.00 previously

    3/3/26 8:38:05 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    Wells Fargo initiated coverage on Fortinet with a new price target

    Wells Fargo initiated coverage of Fortinet with a rating of Underweight and set a new price target of $64.00

    3/3/26 8:27:14 AM ET
    $FTNT
    Computer peripheral equipment
    Technology

    $AAPL
    $ARBB
    $BDRX
    $BILL
    Leadership Updates

    Live Leadership Updates

    View All

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    Fox Factory Announces Strategic Board Refresh

    Company to Appoint Two New Independent Directors and Form Transformation Committee Focused on Operational Excellence and Margin Improvement Company Enters into Cooperation Agreement with Engine Capital DULUTH, Ga., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Fox Factory Holding Corp. (Nasdaq: FOXF) ("Fox Factory" or the "Company"), a premium brand and a global leader in the design, engineering and manufacturing of performance-defining products and systems for customers worldwide, today announced that following constructive discussions with Engine Capital ("Engine Capital") regarding opportunities to enhance operational performance and profitability, the Company will be undertaking a strategic boar

    2/9/26 4:05:00 PM ET
    $FOXF
    $OFIX
    Motor Vehicles
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care

    DigitalOcean Appoints Vinay Kumar as Chief Product and Technology Officer

    DigitalOcean (NYSE:DOCN) today announced the appointment of Vinay Kumar as Chief Product and Technology Officer (CPTO). In this role, Vinay will lead product strategy, product development, cloud infrastructure, and security, with responsibility for defining and executing DigitalOcean's platform roadmap as the company scales its AI inference cloud and core cloud offerings. Vinay brings more than a decade of senior leadership experience building, operating, and scaling large-scale cloud platforms and mission-critical infrastructure. He was one of the founding members of Oracle Cloud Infrastructure (OCI), where he helped build and scale OCI from inception into a global hyperscale cloud platf

    1/20/26 8:05:00 AM ET
    $DOCN
    Computer Software: Programming Data Processing
    Technology

    $AAPL
    $ARBB
    $BDRX
    $BILL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Biodexa Pharmaceuticals plc American Depositary Shs

    SC 13G/A - Biodexa Pharmaceuticals Plc (0001643918) (Subject)

    11/20/24 11:56:39 AM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Biodexa Pharmaceuticals plc American Depositary Shs

    SC 13G/A - Biodexa Pharmaceuticals Plc (0001643918) (Subject)

    11/14/24 5:12:47 PM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Altamira Therapeutics Ltd.

    SC 13G - Altamira Therapeutics Ltd. (0001601936) (Subject)

    11/14/24 3:27:52 PM ET
    $CYTO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAPL
    $ARBB
    $BDRX
    $BILL
    Financials

    Live finance-specific insights

    View All

    InflaRx to Report Full Year 2025 Results on March 19, 2026

    JENA, Germany, March 12, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (NASDAQ:IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company will publish its financial and operating results for the fourth quarter and full year 2025 on March 19, 2026, before the market opens. No conference call is planned. About InflaRxInflaRx (NASDAQ:IFRX) is a biopharmaceutical company pioneering anti-inflammatory therapeutics by applying its proprietary anti-C5a and anti-C5aR technologies to discover, develop and commercialize highly potent and specific inhibitors of the complement activation factor C5a and its receptor, C5aR. C

    3/12/26 7:30:00 AM ET
    $IFRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Fox Factory Holding Corp. Reports Fourth Quarter Fiscal 2025 Financial Results

    Announces Phase 2 of Profit Optimization Plan with Targeted Incremental Savings of Approximately $40 Million to be Realized in 2026 Introduces Fiscal 2026 Adjusted EBITDA Guidance that Implies Approximately 200 Basis Points of Margin Improvement at the Midpoint DULUTH, Ga., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Fox Factory Holding Corp. (NASDAQ:FOXF) ("FOX" or the "Company"), a premium brand and a global leader in the design, engineering and manufacturing of performance-defining products and systems for customers worldwide, today reported financial results for the fourth fiscal quarter ended January 2, 2026. Fourth Quarter Fiscal 2025 Highlights Net sales increased 2.3% year-over-year to $

    2/26/26 4:05:00 PM ET
    $FOXF
    Motor Vehicles
    Consumer Discretionary

    Hippo Reports Fourth Quarter 2025 Financial Results

    SAN JOSE, Calif., Feb. 25, 2026 /PRNewswire/ -- Hippo Holdings Inc. (NYSE:HIPO), a technology-native insurance platform driving growth across owned and partner MGAs, announced its consolidated financial results including diluted earnings per share of $0.23 and diluted adjusted earnings per share of $0.67 for the quarter ended December 31, 2025. Fourth Quarter HighlightsGross Written Premium increased 40% to $288 million over 4Q24Net Written Premium increased 23% to $97 million over 4Q24Net Income attributable to Hippo of $6 million compared to $44 million in 4Q24Adjusted Net Inc

    2/25/26 7:00:00 AM ET
    $HIPO
    Property-Casualty Insurers
    Finance